TARDBP and dementia: Lastly, although we evaluated patients with both sporadic and genetic forms of dementia with a range of proteinopathies (primary and secondary tauopathies, TDP-43), it would be highly relevant to evaluate other common brain diseases associated with aging to determine the range of possible clinical utility (e.g. alpha-synuclein and cerebrovascular disease).